Medline Holders Price 60 Million Shares — The Company Gets None Of The Proceeds
Existing owners expect about $2.1 billion in net proceeds, while Medline agreed to a separate $200 million repurchase.
Medline, which makes and distributes medical-surgical supplies, had selling stockholders price a 60 million-share offering Tuesday that will send all sale proceeds to those holders. Wednesday's SEC filing put their expected net proceeds at approximately $2.1 billion, excluding an option for additional shares.
$35.50 For Existing Owners' Shares
The Class A shares were priced at $35.50 each, according to Medline's Tuesday pricing release. Medline is selling no shares in the offering and will receive none of the money from it.
The sellers are affiliates of Blackstone, Carlyle and Hellman & Friedman, as well as GIC and a managed affiliate, and a subsidiary wholly owned by the Abu Dhabi Investment Authority. All except the Abu Dhabi Investment Authority subsidiary beneficially own more than 5% of Medline's Class A stock.
Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan lead the sale. The underwriters can purchase up to 9 million additional shares under a 30-day option.
The holders launched the sale Monday. The registration statement was awaiting effectiveness at launch; the SEC had declared it effective by Tuesday's pricing announcement.
Medline's Separate $200 Million Purchase
Medline and Medline Holdings, its partnership, agreed Monday to buy back $200 million of Class A shares and partnership interests directly from the same sellers. They will pay the per-interest price paid by the offering's underwriters.
The purchase counts toward Medline's previously announced buyback program. Its board's audit committee, composed entirely of independent directors, approved the transaction.
Sellers whose partnership interests are repurchased will transfer matching amounts of Class B stock to Medline without additional payment. Medline will cancel those Class B shares.
Supplying Hospitals And Surgery Centers
Medline supplies hospitals, surgery centers, physician offices and post-acute facilities. Its Medline Brand segment sells own-brand items including wound-care products, examination gloves, surgical procedure trays and laboratory and diagnostic supplies.
Supply Chain Solutions distributes other suppliers' products and provides logistics and outsourced warehouse management. Many customers use Prime Vendor contracts, typically lasting five years, to purchase most of their medical-surgical supplies from Medline.
The company's 2025 annual report described about 335,000 products across the segments, 70 distribution and related facilities, including 45 in the United States, and 30 manufacturing facilities. It employed more than 45,000 people worldwide as of December 31, 2025.
Medline expects the offering and repurchase to close Monday. The repurchase requires the offering to close, but the offering can proceed without the repurchase.
Sources
- 8-K Filing — Medline Inc. (MDLN) — SEC EDGAR
- Exhibit mdln-ex99_1.htm — Medline Inc. 8-K exhibit — SEC EDGAR
- Medline Inc. announces pricing of secondary offering of Class A common stock – Company Announcement - FT.com — Financial Times
- Medline Inc. announces launch of secondary offering of Class A common stock — Yahoo Finance
- Medline Inc. announces launch of secondary offering of — globenewswire.com
- Medline Inc. announces pricing of secondary offering of — globenewswire.com